AXL inhibition represents a novel therapeutic approach in BCR-ABL negative myeloproliferative neoplasms

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Beitzen-Heineke, Antonia (VerfasserIn) , Berenbrok, Nikolaus (VerfasserIn) , Waizenegger, Jonas S. (VerfasserIn) , Paesler, Sarina (VerfasserIn) , Gensch, Victoria (VerfasserIn) , Udonta, Florian (VerfasserIn) , Vargas Delgado, Maria Elena (VerfasserIn) , Engelmann, Janik (VerfasserIn) , Hoffmann, Friederike (VerfasserIn) , Schafhausen, Philippe (VerfasserIn) , Amsberg, Gunhild von (VerfasserIn) , Riecken, Kristoffer (VerfasserIn) , Beumer, Niklas (VerfasserIn) , Imbusch, Charles (VerfasserIn) , Lorens, James (VerfasserIn) , Fischer, Thomas (VerfasserIn) , Pantel, Klaus (VerfasserIn) , Bokemeyer, Carsten (VerfasserIn) , Ben-Batalla, Isabel (VerfasserIn) , Loges, Sonja (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2021
In: HemaSphere
Year: 2021, Jahrgang: 5, Heft: 9, Pages: 1-13
ISSN:2572-9241
Online-Zugang:Resolving-System, kostenfrei: https://journals.lww.com/hemasphere/Fulltext/2021/09000/AXL_Inhibition_Represents_a_Novel_Therapeutic.2.aspx
Volltext
Verfasserangaben:Antonia Beitzen-Heineke, Nikolaus Berenbrok, Jonas Waizenegger, Sarina Paesler, Victoria Gensch, Florian Udonta, Maria Elena Vargas Delgado, Janik Engelmann, Friederike Hoffmann, Philippe Schafhausen, Gunhild von Amsberg, Kristoffer Riecken, Niklas Beumer, Charles D. Imbusch, James Lorens, Thomas Fischer, Klaus Pantel, Carsten Bokemeyer, Isabel Ben-Batalla, Sonja Loges

MARC

LEADER 00000caa a2200000 c 4500
001 176994981X
003 DE-627
005 20240416142543.0
007 cr uuu---uuuuu
008 210909s2021 xx |||||o 00| ||eng c
024 7 |a 10.1097/HS9.0000000000000630  |2 doi 
035 |a (DE-627)176994981X 
035 |a (DE-599)KXP176994981X 
035 |a (OCoLC)1425218030 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 32  |2 sdnb 
100 1 |a Beitzen-Heineke, Antonia  |d 1987-  |e VerfasserIn  |0 (DE-588)1131195507  |0 (DE-627)88557320X  |0 (DE-576)487878213  |4 aut 
245 1 0 |a AXL inhibition represents a novel therapeutic approach in BCR-ABL negative myeloproliferative neoplasms  |c Antonia Beitzen-Heineke, Nikolaus Berenbrok, Jonas Waizenegger, Sarina Paesler, Victoria Gensch, Florian Udonta, Maria Elena Vargas Delgado, Janik Engelmann, Friederike Hoffmann, Philippe Schafhausen, Gunhild von Amsberg, Kristoffer Riecken, Niklas Beumer, Charles D. Imbusch, James Lorens, Thomas Fischer, Klaus Pantel, Carsten Bokemeyer, Isabel Ben-Batalla, Sonja Loges 
264 1 |c 2021 
300 |a 13 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
700 1 |a Berenbrok, Nikolaus  |e VerfasserIn  |4 aut 
700 1 |a Waizenegger, Jonas S.  |e VerfasserIn  |0 (DE-588)1115012452  |0 (DE-627)869466100  |0 (DE-576)477620981  |4 aut 
700 1 |a Paesler, Sarina  |e VerfasserIn  |4 aut 
700 1 |a Gensch, Victoria  |d 1981-  |e VerfasserIn  |0 (DE-588)1326340646  |0 (DE-627)1885959524  |4 aut 
700 1 |a Udonta, Florian  |e VerfasserIn  |4 aut 
700 1 |a Vargas Delgado, Maria Elena  |e VerfasserIn  |4 aut 
700 1 |a Engelmann, Janik  |e VerfasserIn  |4 aut 
700 1 |a Hoffmann, Friederike  |e VerfasserIn  |4 aut 
700 1 |a Schafhausen, Philippe  |d 1963-  |e VerfasserIn  |0 (DE-588)121852806  |0 (DE-627)081576935  |0 (DE-576)292919107  |4 aut 
700 1 |a Amsberg, Gunhild von  |d 1977-  |e VerfasserIn  |0 (DE-588)128531363  |0 (DE-627)374211523  |0 (DE-576)297198416  |4 aut 
700 1 |a Riecken, Kristoffer  |e VerfasserIn  |0 (DE-588)1045248657  |0 (DE-627)773951164  |0 (DE-576)398864934  |4 aut 
700 1 |a Beumer, Niklas  |d 1996-  |e VerfasserIn  |0 (DE-588)1312234334  |0 (DE-627)1872029817  |4 aut 
700 1 |a Imbusch, Charles  |e VerfasserIn  |0 (DE-588)1193524474  |0 (DE-627)1672263824  |4 aut 
700 1 |a Lorens, James  |e VerfasserIn  |4 aut 
700 1 |a Fischer, Thomas  |d 1958-  |e VerfasserIn  |0 (DE-588)1257794345  |0 (DE-627)1802480323  |4 aut 
700 1 |a Pantel, Klaus  |d 1960-  |e VerfasserIn  |0 (DE-588)1027683606  |0 (DE-627)729554929  |0 (DE-576)373549997  |4 aut 
700 1 |a Bokemeyer, Carsten  |d 1963-  |e VerfasserIn  |0 (DE-588)1028099762  |0 (DE-627)730356930  |0 (DE-576)375642625  |4 aut 
700 1 |a Ben-Batalla, Isabel  |e VerfasserIn  |0 (DE-588)104735411X  |0 (DE-627)778156575  |0 (DE-576)400939002  |4 aut 
700 1 |a Loges, Sonja  |d 1973-  |e VerfasserIn  |0 (DE-588)129285463  |0 (DE-627)480392161  |0 (DE-576)297579002  |4 aut 
773 0 8 |i Enthalten in  |t HemaSphere  |d Hoboken : John Wiley & Sons Ltd., 2017  |g 5(2021), 9, Artikel-ID e630, Seite 1-13  |h Online-Ressource  |w (DE-627)1015324924  |w (DE-600)2922183-3  |w (DE-576)500571066  |x 2572-9241  |7 nnas  |a AXL inhibition represents a novel therapeutic approach in BCR-ABL negative myeloproliferative neoplasms 
773 1 8 |g volume:5  |g year:2021  |g number:9  |g elocationid:e630  |g pages:1-13  |g extent:13  |a AXL inhibition represents a novel therapeutic approach in BCR-ABL negative myeloproliferative neoplasms 
856 4 0 |u https://journals.lww.com/hemasphere/Fulltext/2021/09000/AXL_Inhibition_Represents_a_Novel_Therapeutic.2.aspx  |x Resolving-System  |z kostenfrei 
951 |a AR 
992 |a 20231206 
993 |a Article 
994 |a 2021 
998 |g 1326340646  |a Gensch, Victoria  |m 1326340646:Gensch, Victoria  |p 5 
998 |g 129285463  |a Loges, Sonja  |m 129285463:Loges, Sonja  |d 60000  |d 63600  |e 60000PL129285463  |e 63600PL129285463  |k 0/60000/  |k 1/60000/63600/  |p 20  |y j 
998 |g 1193524474  |a Imbusch, Charles  |m 1193524474:Imbusch, Charles  |d 140000  |e 140000PI1193524474  |k 0/140000/  |p 14 
998 |g 1312234334  |a Beumer, Niklas  |m 1312234334:Beumer, Niklas  |d 140000  |e 140000PB1312234334  |k 0/140000/  |p 13 
999 |a KXP-PPN176994981X  |e 442722248X 
BIB |a Y 
SER |a journal 
JSO |a {"type":{"media":"Online-Ressource","bibl":"article-journal"},"title":[{"title_sort":"AXL inhibition represents a novel therapeutic approach in BCR-ABL negative myeloproliferative neoplasms","title":"AXL inhibition represents a novel therapeutic approach in BCR-ABL negative myeloproliferative neoplasms"}],"name":{"displayForm":["Antonia Beitzen-Heineke, Nikolaus Berenbrok, Jonas Waizenegger, Sarina Paesler, Victoria Gensch, Florian Udonta, Maria Elena Vargas Delgado, Janik Engelmann, Friederike Hoffmann, Philippe Schafhausen, Gunhild von Amsberg, Kristoffer Riecken, Niklas Beumer, Charles D. Imbusch, James Lorens, Thomas Fischer, Klaus Pantel, Carsten Bokemeyer, Isabel Ben-Batalla, Sonja Loges"]},"origin":[{"dateIssuedDisp":"2021","dateIssuedKey":"2021"}],"person":[{"role":"aut","display":"Beitzen-Heineke, Antonia","family":"Beitzen-Heineke","given":"Antonia"},{"role":"aut","display":"Berenbrok, Nikolaus","family":"Berenbrok","given":"Nikolaus"},{"given":"Jonas S.","display":"Waizenegger, Jonas S.","role":"aut","family":"Waizenegger"},{"given":"Sarina","display":"Paesler, Sarina","role":"aut","family":"Paesler"},{"given":"Victoria","family":"Gensch","display":"Gensch, Victoria","role":"aut"},{"display":"Udonta, Florian","role":"aut","family":"Udonta","given":"Florian"},{"family":"Vargas Delgado","role":"aut","display":"Vargas Delgado, Maria Elena","given":"Maria Elena"},{"role":"aut","display":"Engelmann, Janik","family":"Engelmann","given":"Janik"},{"role":"aut","display":"Hoffmann, Friederike","family":"Hoffmann","given":"Friederike"},{"given":"Philippe","role":"aut","display":"Schafhausen, Philippe","family":"Schafhausen"},{"given":"Gunhild von","family":"Amsberg","display":"Amsberg, Gunhild von","role":"aut"},{"family":"Riecken","display":"Riecken, Kristoffer","role":"aut","given":"Kristoffer"},{"role":"aut","display":"Beumer, Niklas","family":"Beumer","given":"Niklas"},{"given":"Charles","family":"Imbusch","display":"Imbusch, Charles","role":"aut"},{"given":"James","role":"aut","display":"Lorens, James","family":"Lorens"},{"given":"Thomas","family":"Fischer","role":"aut","display":"Fischer, Thomas"},{"role":"aut","display":"Pantel, Klaus","family":"Pantel","given":"Klaus"},{"role":"aut","display":"Bokemeyer, Carsten","family":"Bokemeyer","given":"Carsten"},{"given":"Isabel","display":"Ben-Batalla, Isabel","role":"aut","family":"Ben-Batalla"},{"family":"Loges","display":"Loges, Sonja","role":"aut","given":"Sonja"}],"id":{"doi":["10.1097/HS9.0000000000000630"],"eki":["176994981X"]},"language":["eng"],"recId":"176994981X","physDesc":[{"extent":"13 S."}],"relHost":[{"origin":[{"publisherPlace":"Hoboken ; [Philadelphia, Pennsylvania]","dateIssuedKey":"2024","publisher":"John Wiley & Sons Ltd. ; Wolters Kluwer Health","dateIssuedDisp":"2024-"}],"id":{"eki":["1015324924"],"issn":["2572-9241"],"zdb":["2922183-3"]},"part":{"year":"2021","text":"5(2021), 9, Artikel-ID e630, Seite 1-13","pages":"1-13","issue":"9","extent":"13","volume":"5"},"title":[{"title":"HemaSphere","title_sort":"HemaSphere","subtitle":"open access journal of the European Hematology Association"}],"disp":"AXL inhibition represents a novel therapeutic approach in BCR-ABL negative myeloproliferative neoplasmsHemaSphere","pubHistory":["Volume 1, issue 1 (December 2017)-"],"language":["eng"],"type":{"bibl":"periodical","media":"Online-Ressource"},"recId":"1015324924","physDesc":[{"extent":"Online-Ressource"}],"note":["Gesehen am 18.01.2024"],"corporate":[{"display":"European Hematology Association","role":"isb"}]}]} 
SRT |a BEITZENHEIAXLINHIBIT2021